Gene · 3601
Papers2,328
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,328
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Genetics of Postoperative Recurrence in Crohn Disease: A Systematic Review, Meta-analysis, and Framework for Future Work. | Crohns Colitis 360 | 2021 | 36778938 | PubTator, text mining | PubMed |
| Identification and expression analysis of IL-2 receptors in large yellow croaker (Larimichthys crocea). | Fish Shellfish Immunol Rep | 2021 | 36420493 | PubTator, text mining | PubMed |
| Beyond Ipilimumab: a review of immunotherapeutic approaches in clinical trials in melanoma. | Immunother Adv | 2021 | 36284898 | PubTator, text mining | PubMed |
| CSF1R defines the mononuclear phagocyte system lineage in human blood in health and COVID-19. | Immunother Adv | 2021 | 35915730 | PubTator, text mining | PubMed |
| Placental Macrophage (Hofbauer Cell) Responses to Infection During Pregnancy: A Systematic Scoping Review. | Front Immunol | 2021 | 35250964 | PubTator, text mining | PubMed |
| Cyclooxygenase 2 Effector Genes as Potential Inflammation-Related Biomarkers for Colorectal Cancer Circulating Tumor Cells Detection by Liquid Biopsy. | Front Pharmacol | 2021 | 35153760 | PubTator, text mining | PubMed |
| The Cancer Surfaceome Atlas integrates genomic, functional and drug response data to identify actionable targets. | Nat Cancer | 2021 | 35121907 | PubTator, text mining | PubMed |
| Exosomes: Biological Pharmaceutical Nanovectors for Theranostics. | Front Bioeng Biotechnol | 2021 | 35096795 | PubTator, text mining | PubMed |
| Role of IL-10-Producing Natural Killer Cells in the Regulatory Mechanisms of Inflammation during Systemic Infection. | Biomolecules | 2021 | 35053151 | PubTator, text mining | PubMed |
| COVID-19 Transcriptomic Atlas: A Comprehensive Analysis of COVID-19 Related Transcriptomics Datasets. | Front Genet | 2021 | 35003208 | PubTator, text mining | PubMed |
| Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid Leukemia. | Front Immunol | 2021 | 34975835 | PubTator, text mining | PubMed |
| Immune Cell-Derived Extracellular Vesicles - New Strategies in Cancer Immunotherapy. | Front Immunol | 2021 | 34956197 | PubTator, text mining | PubMed |
| NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful Development. | Cells | 2021 | 34943898 | PubTator, text mining | PubMed |
| Multiomics Provide Insights into the Key Molecules and Pathways Involved in the Physiological Adaptation of Atlantic Salmon (Salmo salar) to Chemotherapeutic-Induced Oxidative Stress. | Antioxidants (Basel) | 2021 | 34943035 | PubTator, text mining | PubMed |
| Transcriptomics of single dose and repeated carbon black and ozone inhalation co-exposure highlight progressive pulmonary mitochondrial dysfunction. | Part Fibre Toxicol | 2021 | 34911549 | PubTator, text mining | PubMed |
| Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies. | Arch Immunol Ther Exp (Warsz) | 2021 | 34897554 | PubTator, text mining | PubMed |
| Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities. | J Immunother Cancer | 2021 | 34896980 | PubTator, text mining | PubMed |
| The role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinoma. | J Transl Genet Genom | 2021 | 34888493 | PubTator, text mining | PubMed |
| Vaccine-Based Immunotherapy for Head and Neck Cancers. | Cancers (Basel) | 2021 | 34885150 | PubTator, text mining | PubMed |
| The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance. | Cancers (Basel) | 2021 | 34885122 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3601/papers?page=34